Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene (Q34413507)

2 August 2017

title

Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene (English)

1 reference

2 August 2017

G De Sarro

1

1 reference

2 August 2017

E Donato Di Paola

2

1 reference

2 August 2017

U Falconi

3

1 reference

2 August 2017

G Ferreri

4

1 reference

2 August 2017

A De Sarro

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

European Journal of Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

317

1 reference

2 August 2017

issue

2-3

1 reference

2 August 2017

page(s)

239-245

1 reference

Prolonged agonist exposure induces imbalance of A1 and A2 receptor-mediated functions in rat brain slices

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Anticonvulsant effects of adenosine analogues on amygdaloid-kindled seizures in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Central versus peripheral mediation of responses to adenosine receptor agonists: evidence against a central mode of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Physiological and pharmacological properties of adenosine: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Anticonvulsant actions of DS 103-282. Pharmacological studies in rodents and the baboon, Papio papio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Anticonvulsant action of 2-chloroadenosine injected focally into the inferior colliculus and substantia nigra.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Anticonvulsant effects of some calcium entry blockers in DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Neuroprotective effects of adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Is adenosine an endogenous anticonvulsant?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

NECA-induced hypomotility in mice: evidence for a predominantly central site of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Adenosine receptor ligands: differences with acute versus chronic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

N6-cyclopentyladenosine impairs passive avoidance retention by selective action at A1 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

The role of adenosine and its nucleotides in central synaptic transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Multiple components of the A1 adenosine receptor-adenylate cyclase system are regulated in rat cerebral cortex by chronic caffeine ingestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Prolonged postictal depression in amygdala-kindled rats by the adenosine analog, L-phenylisopropyladenosine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Neuroprotective role of adenosine in cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

The effects of adenosine A3 receptor stimulation on seizures in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

Effects of N6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900746-7

10.1016/S0014-2999(96)00746-7

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference